REGMF (RemeGen Co) OCF Margin %: 0.00% (As of Dec. 2025)


REGMF RemeGen Co Ltd REGMF
41 GF Score
Price $12.05
GF Value $31.89
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is RemeGen Co OCF Margin %?

RemeGen Co REGMF -6.23% 41 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates REGMF with a GF Score™ of 41/100 and a GF Value™ of $31.89 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 958 Biotechnology companies, RemeGen Co ranks better than 70.35% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. RemeGen Co's Cash Flow from Operations for the three months ended in Dec. 2025 was $0.0 Mil. RemeGen Co's Revenue for the three months ended in Dec. 2025 was $216.1 Mil. Therefore, RemeGen Co's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, RemeGen Co's current OCF Yield % is 0.10%.

The historical rank and industry rank for RemeGen Co's OCF Margin % or its related term are showing as below:

REGMF' s OCF Margin % Range Over the Past 10 Years
Min: -1130.88   Med: -104.18   Max: 18.51
Current: 2.44

During the past 8 years, the highest OCF Margin % of RemeGen Co was 18.51%. The lowest was -1130.88%. And the median was -104.18%.

REGMF's OCF Margin % is ranked better than
70.35% of 958 companies
in the Biotechnology industry
Industry Median: -68.59 vs REGMF: 2.44

RemeGen Co OCF Margin % Related Terms

RemeGen Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for RemeGen Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RemeGen Co OCF Margin % Chart

RemeGen Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 18.51 -164.59 -139.56 -68.80 1.61

RemeGen Co Quarterly Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

REGMF vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, RemeGen Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RemeGen Co OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RemeGen Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where RemeGen Co's OCF Margin % falls into.


REGMF
41GF Score
RemeGen Co Ltd REGMF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RemeGen Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

RemeGen Co's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=7.432/460.24
=1.61 %

RemeGen Co's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/216.056
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
RemeGen Co (REGMF) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on RemeGen Co and its competitors. According to the industry distribution chart, RemeGen Co ranks #284 out of 958 companies in the Biotechnology industry, placing it in the top 29.6%.
Is RemeGen Co's OCF Margin % too high?
RemeGen Co's current OCF Margin % is 0.00%. Based on the distribution chart, RemeGen Co ranks #284 out of 958 companies in the Biotechnology industry, which is above the industry midpoint. Overall, RemeGen Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does RemeGen Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, RemeGen Co ranks #284 out of 958 companies for OCF Margin %. This puts RemeGen Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on RemeGen Co and its competitors. RemeGen Co's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RemeGen Co stock overvalued right now?
Based on GuruFocus' analysis, RemeGen Co (REGMF) is currently considered Possible Value Trap. The stock's GF Value™ is $31.89, compared to a current price of $12.05 — trading 62.2% below its estimated fair value. The current OCF Margin % is 0.00%. RemeGen Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For RemeGen Co (REGMF), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RemeGen Co (REGMF) Overvalued in 2026?

Based on GuruFocus' analysis, RemeGen Co stock appears to be undervalued. The current stock price of $12.05 is trading 62.2% below its estimated GF Value™ of $31.89. GuruFocus considers RemeGen Co to be Possible Value Trap.

Key valuation signals for REGMF:

  • OCF Margin %: 0.00%
  • GF Value™: $31.89 vs. price of $12.05 (62.2% below fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the REGMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RemeGen Co Business Description

Address 58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN
RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat severe diseases such as autoimmune diseases, oncology, and ophthalmology. It has its operations in China and the USA and derives the majority of its revenue from China.
41GF Score

Get the complete analysis for REGMF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.05
Price
$31.89
GF Value